Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Neuromyelitis optica: Contribution of therapeutic responses markers monitoring in patients given rituximab.
Multiple sclerosis influences the precision of the ankle plantarflexon muscular force production.
Correction: Predicting Relapsing-Remitting Dynamics in Multiple Sclerosis Using Discrete Distribution Models: A Population Approach.
HHV-6-positivity in diseases with demyelination.
Patient-specific early classification of multivariate observations.
Galactorrhea in a Patient With Aquaporin-4 Antibody-positive Neuromyelitis Optica Spectrum Disorder: A Case Report and Review of the Literature.
Correction: The Nuclear IκB Family Protein IκBNS Influences the Susceptibility to Experimental Autoimmune Encephalomyelitis in a Murine Model.
Application of metabolomics in autoimmune diseases: Insight into biomarkers and pathology.
Smoking worsens multiple sclerosis prognosis: Two different pathways are involved.
Protection in antibody- and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs.
A Feasibility Study to Investigate the Effect of Functional Electrical Stimulation and Physiotherapy Exercise on the Quality of Gait of People With Multiple Sclerosis.
Serum paraoxonase and arylesterase activity and oxidative status in patients with multiple sclerosis.
Psoriasis and comorbidities. Epidemiological studies.
A gene expression study denies the ability of 25 candidate biomarkers to predict the interferon-beta treatment response in multiple sclerosis patients.
Alemtuzumab and Multiple Sclerosis: Another Note of Caution.
Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression.
Frequency, characteristics and consequences of falls in multiple sclerosis: findings from a cohort study.
Management of faecal incontinence and constipation in adults with central neurological diseases.
Pharmacological Alternatives for the Treatment of Neurodegenerative Disorders: Wasp and Bee Venoms and Their Components as New Neuroactive Tools.
Grammatical Class Effects Across Impaired Child and Adult Populations.
Role of Glia in Stress-Induced Enhancement and Impairment of Memory.
Type I interferon in human autoimmunity.
[Genome-wide association study as a method for genetic architecture analysis in polygenic diseases (by the example of multiple sclerosis)].
Epstein Barr Virus and Mycobacterium avium subsp. paratuberculosis peptides are recognized in sera and cerebrospinal fluid of MS patients.
5-Aminoisoquinolin-1-one (5-AIQ), a Water-Soluble Inhibitor of the Poly¬(ADP Ribose)¬Polymerases (PARPs).
Pages
« first
‹ previous
…
688
689
690
691
692
693
694
695
696
…
next ›
last »